1bn5: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 25: Line 25:
[[Category: methionine aminopeptidase]]
[[Category: methionine aminopeptidase]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Oct 30 14:29:08 2007''
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Oct 30 14:56:07 2007''

Revision as of 15:51, 30 October 2007

File:1bn5.gif


1bn5, resolution 1.8Å

Drag the structure with the mouse to rotate

HUMAN METHIONINE AMINOPEPTIDASE 2

OverviewOverview

The fungal metabolite fumagillin suppresses the formation of new blood, vessels, and a fumagillin analog is currently in clinical trials as an, anticancer agent. The molecular target of fumagillin is methionine, aminopeptidase-2 (MetAP-2). A 1.8 A resolution crystal structure of free, and inhibited human MetAP-2 shows a covalent bond formed between a, reactive epoxide of fumagillin and histidine-231 in the active site of, MetAP-2. Extensive hydrophobic and water-mediated polar interactions with, other parts of fumagillin provide additional affinity. Fumagillin-based, drugs inhibit MetAP-2 but not MetAP-1, and the three-dimensional structure, also indicates the likely determinants of this specificity. The structural, basis for fumagillin's potency and specificity forms the starting point, ... [(full description)]

About this StructureAbout this Structure

1BN5 is a [Single protein] structure of sequence from [Homo sapiens] with CO and TBU as [ligands]. Active as [Methionyl aminopeptidase], with EC number [3.4.11.18]. Structure known Active Site: CO2. Full crystallographic information is available from [OCA].

ReferenceReference

Structure of human methionine aminopeptidase-2 complexed with fumagillin., Liu S, Widom J, Kemp CW, Crews CM, Clardy J, Science. 1998 Nov 13;282(5392):1324-7. PMID:9812898

Page seeded by OCA on Tue Oct 30 14:56:07 2007

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA